Omada Health Statistics
Total Valuation
Omada Health has a market cap or net worth of $1.48 billion. The enterprise value is $1.26 billion.
| Market Cap | 1.48B |
| Enterprise Value | 1.26B |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Omada Health has 61.22 million shares outstanding. The number of shares has increased by 433.19% in one year.
| Current Share Class | 61.22M |
| Shares Outstanding | 61.22M |
| Shares Change (YoY) | +433.19% |
| Shares Change (QoQ) | +8.53% |
| Owned by Insiders (%) | 2.79% |
| Owned by Institutions (%) | 76.39% |
| Float | 50.85M |
Valuation Ratios
The trailing PE ratio is 329.10 and the forward PE ratio is 49.90.
| PE Ratio | 329.10 |
| Forward PE | 49.90 |
| PS Ratio | 4.80 |
| Forward PS | 4.02 |
| PB Ratio | 5.68 |
| P/TBV Ratio | 6.25 |
| P/FCF Ratio | 65.46 |
| P/OCF Ratio | 62.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 233.08, with an EV/FCF ratio of 55.70.
| EV / Earnings | 294.04 |
| EV / Sales | 4.09 |
| EV / EBITDA | 233.08 |
| EV / EBIT | n/a |
| EV / FCF | 55.70 |
Financial Position
The company has a current ratio of 3.91
| Current Ratio | 3.91 |
| Quick Ratio | 3.70 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.17 |
Financial Efficiency
Return on equity (ROE) is 1.84% and return on invested capital (ROIC) is -0.12%.
| Return on Equity (ROE) | 1.84% |
| Return on Assets (ROA) | -0.09% |
| Return on Invested Capital (ROIC) | -0.12% |
| Return on Capital Employed (ROCE) | -0.18% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $327,441 |
| Profits Per Employee | $4,551 |
| Employee Count | 946 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 25.97 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.24% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +2.24% |
| 50-Day Moving Average | 22.31 |
| 200-Day Moving Average | 16.94 |
| Relative Strength Index (RSI) | 58.83 |
| Average Volume (20 Days) | 1,381,161 |
Short Selling Information
The latest short interest is 5.89 million, so 9.62% of the outstanding shares have been sold short.
| Short Interest | 5.89M |
| Short Previous Month | 7.63M |
| Short % of Shares Out | 9.62% |
| Short % of Float | 11.58% |
| Short Ratio (days to cover) | 3.72 |
Income Statement
In the last 12 months, Omada Health had revenue of $309.76 million and earned $4.31 million in profits. Earnings per share was $0.07.
| Revenue | 309.76M |
| Gross Profit | 211.21M |
| Operating Income | -464,000 |
| Pretax Income | 4.31M |
| Net Income | 4.31M |
| EBITDA | 5.43M |
| EBIT | -464,000 |
| Earnings Per Share (EPS) | $0.07 |
Balance Sheet
The company has $221.71 million in cash and no debt, with a net cash position of $221.71 million or $3.62 per share.
| Cash & Cash Equivalents | 221.71M |
| Total Debt | n/a |
| Net Cash | 221.71M |
| Net Cash Per Share | $3.62 |
| Equity (Book Value) | 252.74M |
| Book Value Per Share | 4.17 |
| Working Capital | 219.43M |
Cash Flow
In the last 12 months, operating cash flow was $23.69 million and capital expenditures -$960,000, giving a free cash flow of $22.73 million.
| Operating Cash Flow | 23.69M |
| Capital Expenditures | -960,000 |
| Depreciation & Amortization | 5.90M |
| Net Borrowing | -30.96M |
| Free Cash Flow | 22.73M |
| FCF Per Share | $0.37 |
Margins
Gross margin is 68.19%, with operating and profit margins of -0.15% and 1.39%.
| Gross Margin | 68.19% |
| Operating Margin | -0.15% |
| Pretax Margin | 1.39% |
| Profit Margin | 1.39% |
| EBITDA Margin | 1.75% |
| EBIT Margin | -0.15% |
| FCF Margin | 7.34% |
Dividends & Yields
Omada Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -433.19% |
| Shareholder Yield | -433.19% |
| Earnings Yield | 0.29% |
| FCF Yield | 1.53% |
Analyst Forecast
The average price target for Omada Health is $28.25, which is 16.69% higher than the current price. The consensus rating is "Buy".
| Price Target | $28.25 |
| Price Target Difference | 16.69% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 23.67% |
| EPS Growth Forecast (3Y) | 71.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Omada Health has an Altman Z-Score of 7.97 and a Piotroski F-Score of 4.
| Altman Z-Score | 7.97 |
| Piotroski F-Score | 4 |